Physician profile
Christopher Lenivy
NPI 1184074338
$4,993.57
in general payments reported to CMS, 2019-2025
13 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $121 · 2022: $66.05 · 2023: $2,688 · 2024: $1,394 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,661 · Food and Beverage: $1,407 · Education: $600 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,660.79 |
| Food and Beverage | $1,406.51 |
| Education | $599.95 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,745.01 | 2023-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $644.70 | 2023 | Na |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.53 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 | |
| Mylan Specialty L.P. | $40.06 | 2022-2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $39.78 | 2022-2023 | Breztri |
| Philips North America LLC | $35.03 | 2023 | |
| Ambu INC. | $33.44 | 2022 | |
| Genentech USA, INC. | $25.83 | 2023 | Xolair |
| Baxter Healthcare | $17.68 | 2023 | Hillrom - Life 2000 Ventilation System |
| United Therapeutics Corporation | $16.39 | 2023 | Tyvaso |
| Glaxosmithkline, LLC. | $13.65 | 2023 | Nucala |
| Electromed, INC. | $13.52 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lenivy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.